DADC
GEVA

D.A. Davidson & Co’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

D.A. Davidson & Co’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$9K – 2368
2015
Q1 		$9K Sell
100
-100
-50% -$10.6K ﹤0.01% 1832
2014
Q4 		$18K Hold
200
– – ﹤0.01% 1709
2014
Q3 		$13K Buy
+200
New +$14.3K ﹤0.01% 1783

D.A. Davidson & Co's GEVA Position: Q2 2015 in Review

D.A. Davidson & Co sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 100 shares — an estimated $9K sold.

D.A. Davidson & Co first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $18K in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • D.A. Davidson & Co reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • D.A. Davidson & Co sold 100 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $9K.
  • D.A. Davidson & Co first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • D.A. Davidson & Co's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $18K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on D.A. Davidson & Co's 13F filing for Q2 2015, filed 14 Aug 2015.